OriginClear (OCLN) 10-Q 21 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 16, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Trading Symbol	OCLN
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		3,056,496,017

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 303,130	$ 609,144
Contracts receivable, less allowance for doubtful accounts of $6,996 and $6,996 respectively	289,689	309,223
Inventory	13,736	13,736
Contract assets	104,383	111,001
Convertible note receivable	103,935	84,900
Prepaid expenses	59,320	46,584
TOTAL CURRENT ASSETS	874,193	1,174,588
NET PROPERTY AND EQUIPMENT	143,519	154,250
OTHER ASSETS
Fair value investment-securities	15,600	22,800
Trademark	4,467	4,467
Security deposit	3,500	3,500
TOTAL OTHER ASSETS	23,567	30,767
TOTAL ASSETS	1,041,279	1,359,605
Current Liabilities
Accounts payable and other payable	1,131,307	987,524
Accrued expenses	1,135,559	1,152,982
Cumulative preferred stock dividends payable	38,443	25,085
Contract liabilities	132,391	112,894
Capital lease, current portion	9,088	9,088
Deferred Income	28,500
Customer deposit	113,950	120,688
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance, net of finance fees of $12,566 and $123,458 respectively	542,649	473,507
Loan payable, related party	204,167	219,841
Promissory note, current portion	110	110
Derivative liabilities	7,415,615	9,360,204
Convertible promissory notes, net of discount of $13,528 and $146,005, respectively	2,717,353	1,580,955
Total Current Liabilities	13,489,132	14,062,878
Long Term Liabilities
Capital lease, long term portion	24,646	26,918
Promissory note, long term portion	74,846	74,867
Convertible promissory notes, net of discount of $0 and $0, respectively	1,068,128	2,076,472
Total Long Term Liabilities	1,167,620	2,178,257
Total Liabilities	14,656,752	16,241,135
COMMITMENTS AND CONTINGENCIES (See Note 11)
SHAREHOLDERS' DEFICIT
Preferred stock value
Common stock, $0.0001 par value, 8,000,000,000 shares authorized 2,775,193,101 and 1,750,487,243 equity shares issued and outstanding, respectively	277,520	175,049
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Additional paid in capital	64,034,329	63,004,472
Accumulated other comprehensive loss	(133)	(134)
Accumulated deficit	(80,139,253)	(79,807,981)
TOTAL SHAREHOLDERS' DEFICIT	(15,823,473)	(16,624,530)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	1,041,279	1,359,605
Series F Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	1,678,000	1,743,000
Series G Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	530,000
Series C
SHAREHOLDERS' DEFICIT
Preferred stock value
Series D-1
SHAREHOLDERS' DEFICIT
Preferred stock value	3,850	3,850
Series E
SHAREHOLDERS' DEFICIT
Preferred stock value	$ 214	$ 214

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Allowance for doubtful accounts	$ 6,996	$ 6,996
Merchant cash advances, net of finance fees	12,566	123,458
Net of discount, current	13,528	146,005
Net of discount, non current	$ 0	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	8,000,000,000	8,000,000,000
Common stock, shares issued	2,775,193,101	1,750,487,243
Common stock, shares outstanding	2,775,193,101	1,750,487,243
Preferred treasury stock, shares outstanding	1,000	1,000
Series F Convertible Preferred Stock
Preferred Stock, shares issued	1,678	1,743
Preferred Stock, shares outstanding	1,678	1,743
Convertible preferred stock, redeemable value	$ 1,678,000	$ 1,743,000
Preferred stock, designated shares	6,000	6,000
Series G Convertible Preferred Stock
Preferred Stock, shares issued	530	0
Preferred Stock, shares outstanding	530	0
Convertible preferred stock, redeemable value	$ 530,000	$ 0
Preferred stock, designated shares	6,000	6,000
Series C
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series D-1
Preferred stock, designated shares	50,000,000	50,000,000
Preferred stock, shares issued	38,500,000	38,500,000
Preferred stock, shares outstanding	38,500,000	38,500,000
Series E
Preferred stock, designated shares	4,000,000	4,000,000
Preferred stock, shares issued	2,139,649	2,139,649
Preferred stock, shares outstanding	2,139,649	2,139,649

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Sales	$ 742,043	$ 1,333,539
Cost of Goods Sold	723,263	959,666
Gross Profit	18,780	373,873
Operating Expenses
Selling and marketing expenses	482,659	341,933
General and administrative expenses	587,070	686,618
Research and development	23,950	43,539
Depreciation and amortization expense	10,729	14,361
Total Operating Expenses	1,104,408	1,086,451
Loss from Operations	(1,085,628)	(712,578)
OTHER INCOME (EXPENSE)
Other income	19,036
Unrealized loss on investment securities	(7,200)
Loss on settlement of convertible notes	(314,295)
Commitment fee	(34,378)	(220,283)
Loss on conversion of debt	(514,404)	(126,330)
Gain (Loss) on net change in derivative liability and conversion of debt	1,944,589	(11,671,543)
Interest expense	(338,992)	(157,582)
TOTAL OTHER INCOME (EXPENSE)	754,356	(12,175,738)
NET LOSS	(331,272)	(12,888,316)
PREFERRED STOCK DIVIDENDS	(38,156)
NET LOSS AVAILABLE TO SHAREHOLDERS	$ (369,428)	$ (12,888,316)
BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$ 0	$ (0.11)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED	1,751,656,273	123,062,170

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 1	$ 11,289	$ 58,618,560	$ (134)	$ (68,461,412)	$ (9,831,696)
Balance, shares at Dec. 31, 2017	4,333	112,888,964
Common stock issuance for conversion of debt		$ 744	192,565			193,309
Common stock issuance for conversion of debt, shares		7,442,162
Common stock issued at fair value for services		$ 1,526	400,986			402,512
Common stock issued at fair value for services, shares		15,256,054
Stock compensation cost			13,032			13,032
Net loss					(12,888,316)	(12,888,316)
Balance at Mar. 31, 2018	$ 1	$ 13,559	59,225,143	(134)	(81,349,728)	(22,111,159)
Balance, shares at Mar. 31, 2018	4,333	135,587,180
Balance at Dec. 31, 2018	$ 4,064	$ 175,049	63,004,472	(134)	(79,807,981)	(16,624,530)
Balance, shares at Dec. 31, 2018	40,640,649	1,750,487,243
Common stock issuance for conversion of debt and accrued interest		$ 62,603	828,652			891,255
Common stock issuance for conversion of debt and accrued interest, shares		626,028,089
Common stock issued at fair value for services		$ 23,308	255,921			279,229
Common stock issued at fair value for services, shares		233,078,882
Common stock issued through a private placement for purchase of Series G Preferred stock		$ 16,560	(16,560)
Common stock issued through a private placement for purchase of Series G Preferred stock, shares		165,598,887
Series G Preferred stock issued through a private placement
Series G Preferred stock issued through a private placement, shares
Stock compensation cost						(15,823,473)
Cumulative preferred stock dividend			(38,156)			(38,156)
Other comprehensive gain				1		1
Net loss					(331,272)	(331,272)
Balance at Mar. 31, 2019	$ 4,064	$ 277,520	$ 64,034,329	$ (133)	$ (80,139,253)	$ (15,823,473)
Balance, shares at Mar. 31, 2019	40,640,649	2,775,193,101

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (331,272)	$ (12,888,316)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	10,729	14,361
Common stock and warrants issued for services	279,229	402,512
Stock option and warrant compensation expense		13,032
(Gain) Loss on net change in valuation of derivative liability	(1,944,589)	11,671,543
Loss on conversion of debt	514,404	126,330
Loss on settlement of debt	314,295
Debt discount recognized as interest expense	132,477	78,958
Unrealized loss on fair value of security	7,200
Amortization of financing cost	110,891
Change in Assets (Increase) Decrease in:
Contracts receivable	19,534	58,293
Contract asset	6,618	(125,478)
Accrued interest on convertible note receivable	(19,035)
Other receivable		(31,331)
Prepaid expenses	(12,736)	29,115
Change in Liabilities Increase (Decrease) in:
Accounts payable	143,784	135,253
Accrued expenses	2,556	52,448
Cumulative preferred stock dividends payable	38,156
Contract liabilities	19,497	(12,850)
Customer deposit	(6,738)
Deferred income	28,500	29,800
NET CASH USED IN OPERATING ACTIVITIES	(686,500)	(446,330)
CASH FLOWS FROM INVESTING ACTIVITIES:
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(2,272)	(2,618)
Payments on loan payable, financing	(41,749)
Payments on loan payable, related party	(15,674)	(7,602)
Payments on promissory note payable, related party	(21)
Payment of cumulative preferred stock dividends	(24,798)
Proceeds from convertible promissory notes		252,750
Payment on redemption of preferred stock	(65,000)
Proceeds for issuance of preferred stock for cash	530,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	418,642	242,530
NET DECREASE IN CASH	(306,014)	(203,800)
CASH BEGINNING OF PERIOD	609,144	439,822
CASH END OF PERIOD	303,130	236,022
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	16,926	678
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest	891,255	193,309
Common stock issued at fair value for supplemental shares		$ 220,283

Organization and Line of Busine

Organization and Line of Business	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) (formerly OriginOil, Inc.) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2018. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company’s revenue is not yet sufficient to cover its operating expenditures and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, raising additional capital and increasing sales. Management believes the existing shareholders, prospective new investors, current and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities. Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Three Months Ended March 31, 2019 The Company has excluded 250,912,025 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,799,009, and shares issuable from convertible preferred stock for the three months ended March 31, 2019, because their impact on the loss per share is anti-dilutive. Three Months Ended March 31, 2018 The Company has excluded 3,714,637 shares of common stock issuable pursuant to outstanding stock options, 40,931,531 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,543,068 and shares of common stock issuable pursuant to outstanding convertible preferred stock for the three months ended March 31, 2018, because their impact on the loss per share is anti-dilutive. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $6,996 as of March 31, 2019 and December 31, 2018, respectively. The net contract receivable balance was $289,689 and $309,223 at March 31, 2019 and December 31, 2018, respectively. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2019, the balances reported for cash, contract receivables, contract assets, prepaid expenses, accounts payable, contract liabilities, and accrued expenses, and derivative instruments approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 15,600 $ 15,600 $ - $ - Total Assets measured at fair value $ 15,600 $ 15,600 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,415,615 $ - $ - $ 7,415,615 Total liabilities measured at fair value $ 7,415,615 $ - $ - $ 7,415,615 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Gain on net change in derivative liability (1,944,589 ) Balance as of March 31, 2019 $ 7,415,615 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/19 Risk free interest rate 2.21% - 2.60% Stock volatility factor 40.0% - 270.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material effect on the Company’s consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s financial statements, which had no material effect. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The impact of the adoption of ASU 2018-07 on the Company’s financial statements did not have a material impact. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements. Reclassification of Expenses During the period, the Company reclassified certain expenses in the prior period ended March 31, 2018 to conform to the current period. There was no material effect to the financial statements.

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock As of April 11, 2018, the Board of Directors authorized an increase in shares of preferred stock, par value $0.0001 per share to 550,000,000 shares from 750,000 shares. The Board adopted a Certificate of Designation establishing the rights, preferences, privileges and other terms of Series D preferred stock and Series D-1 preferred stock, par value $0.0001 per share. The Board authorized and approved 400,000,000 shares of Series D and 50,000,000 shares of Series D-1 preferred stock. Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. Series D On April 13, 2018, the Board adopted resolutions creating a series of shares of convertible preferred stock designated 400,000,000 shares as 0% Series D preferred stock (the “Series D preferred stock”) with a par value of $0.0001. The shares of Series D preferred stock did not have a dividend rate or liquidation preference and did not carry any voting rights. As of August 14, 2018, the Series D preferred stock were cancelled, and exchanged for Series E preferred shares. Series D-1 On April 13, 2018, the Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the “Series D-1 preferred stock”) with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into the greater of (A) one share of common stock and (B) the number of shares of common stock the holder would have received pursuant to each holder’s respective subscription agreement if the Series D-1 Preferred Shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is $0.005 (1/2 of one cent). The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days’ notice. The Company issued an aggregate of 38,500,000 Series D-1 preferred shares for services. As of March 31, 2019, there were 38,500,000 Series D-1 preferred shares issued and outstanding. Series E On August 14, 2018, the Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the “Series E preferred stock”) with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock into a number of shares of common stock equal to the greater of (A) 100 shares of common stock and (B) the number of shares of common stock the holder would have received pursuant to such holder’s respective subscription agreement if the preferred shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is 50% of the purchase price paid by any purchase of the Series E preferred stock. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days’ notice. In connection with the issuance of the Series E preferred stock, the Company also issued one hundred warrants to purchase shares of common stock for each share of Series E preferred stock. As of March 31 2019, there were 2,139,649 shares of Series E preferred stock issued and outstanding. Series F On August 14, 2018, the Company filed a Certificate of Designation for its Series F Convertible preferred stock (the “Series F preferred stock”) with the Secretary of State of Nevada designating 6,000 shares of Series F Preferred Stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F Preferred Stock have a liquidation preference of stated value per share of $1,000 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock or any other series of capital stock (other than the Series B Preferred Stock) then-existing or thereinafter created. The Series F preferred stock is not convertible into common stock. The shares of Series F preferred stock do not carry any voting rights. The holders of Series F Preferred Stock will be entitled to receive, of any funds and assets of the Company legally available prior and in preference to any declaration or payment of any dividend on the common stock, cumulative dividends, payable quarterly (at the end of each fiscal quarter, and due for such fiscal quarter within fifteen days of the end of such fiscal quarter), at an annual rate of 8% of the stated value. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. During the period ended March 31, 2019, 65 shares of Series F were redeemed for a value of $65,000. As of March 31, 2019, the Company accrued dividends in the amount of $33,560. As of March 31, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding. Series G On January 16, 2019, the Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the “Series G Designation”). Pursuant to the Series G Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000, and pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000. As of March 31, 2019, the Company issued an aggregate of 165,598,887 shares of its common stock to certain holders of its Series G preferred stock. As of March 31, 2019, the Company accrued dividends in the amount of $4,596. Common Stock On August 9, 2018, the Company and Board of Directors increased the aggregate number of authorized shares of common stock of the Company to 8,000,000,000 shares from 2,000,000,000 shares. Three months ended March 31, 2019 The Company issued 626,028,089 shares of common stock upon conversion of convertible promissory notes in an aggregate principal in the amount of $284,973, and a default settlement of $40,500, plus interest in the amount of $51,578, with an aggregate fair value loss on conversion of debt in the amount of $514,404, based upon conversion prices of $0.0009 to $0.0018. The Company issued 233,078,882 shares of common stock for services at fair value of $279,229. The Company issued 165,598,887 shares of common stock through a private placement for purchase of Series G preferred stock. Three months ended March 31, 2018 The Company issued 7,442,162 shares of common stock upon conversion of convertible promissory notes in an aggregate principal in the amount of $50,000, plus interest in the amount of $16,979, with an aggregate fair value loss on conversion of debt in the amount of $126,330, based upon conversion prices of $0.019 to $0.0329. The Company issued 15,256,054 shares of common stock for services at fair value of $402,512.

Convertible Promissory Notes

Convertible Promissory Notes	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	4. CONVERTIBLE PROMISSORY NOTES As of March 31, 2019, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes, net of debt discount $ 3,785,481 Less current portion 2,717,353 Total long-term liabilities $ 1,068,128 Maturities of long-term debt for the next five years are as follows: Period Ending March 31, 2019 Amount 2020 2,717,353 2021 970,000 2022 25,000 2023 73,128 $ 3,785,481 At March 31, 2019, the $3,799,009 in convertible promissory notes has a remaining debt discount of $13,528, leaving a net balance of $3,785,481. On various dates, the Company issued unsecured convertible promissory notes (the “Notes”), that matured during the period and were extended sixty (60) days from the effective date of each Note. The Notes bear interest at 10% per year. The Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $2.10 to $4.90 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes. In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the three months ended March 31, 2019, the Company issued 240,595,661 shares of common stock, upon conversion of $86,800 in principal, plus accrued interest of $37,989, with a fair value loss on settlement of $190,873. As of March 31, 2019, the Notes had an aggregate remaining balance of $1,192,500. As of March 31, 2019, the unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining principal balance of $143,228, The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes matured on June 30, 2018, and were extended through June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $15.31. After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. As of March 31, 2019, the remaining balance on the notes was $73,128. The Company issued various, unsecured convertible promissory notes (the “2015-2016 Notes”), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per year. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $0.70 to $2.80 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of March 31, 2019, was $1,325,000. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for an accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of March 31, 2019, the remaining balance on the Dec 2015 Note was $167,048. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the time it was entered into, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of March 31, 2019, the remaining balance on the Sep 2016 Note was $430,896. The Company issued various unsecured convertible promissory notes (the “Jan-Aug 2018 Notes”), in the aggregate amount of $293,000 on various dates from January 24, 2018 thru August 28, 2018. The Jan-Aug 2018 Notes matures on dates from January 24, 2018 thru August 28, 2019. The Jan-Aug 2018 Notes bear interest at 10% per year. The Jan-Aug 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion. The conversion feature of the Jan-Aug 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Aug 2018 Notes. During the three months ended March 31, 2019, the Company issued 148,027,924 shares of common stock, upon conversion of principal in the amount of $81,000, plus accrued interest of $5,903, and a loss on settlement of $40,500, with a fair value loss on conversion of debt in the amount of $99,667. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $42,260 during the three months ended March 31, 2019. As of March 31, 2019, the Jan-Aug 2018 Notes were fully converted. The Company issued two (2) unsecured convertible promissory notes (the “Feb 2018 Notes”), in the aggregate principal amount of $157,500 (each in the amount of $78,750) on February 23, 2018. The Feb 2018 Notes had a maturity date of February 23, 2019, and bear interest at 10% per year. The first of the two Feb 2018 Notes shall be paid for by the Buyer. The second of the two Feb 2018 Notes shall initially be paid for by the issuance of an offsetting $78,750 secured note issued to the Company by the Buyer. The first of the two notes was funded with cash and the Company must agree to the funding of the second of the two Feb 2018 Notes, before it can be funded with cash. The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company’s common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the period ended March 31, 2019, the Company entered into a settlement agreement with the investor in the amount of $20,275 (50% of the outstanding balance of $40,550 as of date of settlement), based on the outstanding balance due and payable under the Notes. During the three months ended March 31, 2019, the Company issued 72,182,282 shares of common stock, upon conversion of principal in the amount of $40,550, plus accrued interest of $2,759, with a fair value loss on settlement of $81,469. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $50,702 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Feb 2018 Notes were $20,275. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes mature on April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the three months ended March 31, 2019, the Company issued 25,000,000 shares of common stock upon conversion of principal in the amount of $6,523, plus accrued interest of $4,727, with a fair value loss on conversion of $16,250. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 5,261,538,462 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but no limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $39,128 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Apr & May 2018 Notes were $515,162. The Company issued an unsecured convertible promissory notes (the “Nov 2018 Note”), in the sum amount of $75,000 on November 30, 2018. The Nov 2018 Note matures on November 30, 2019. The Nov 2018 Note bears interest at 10% per annum. The Nov 2018 Note may be converted into shares of the Company’s common stock at a fixed conversion price of $0.05 per share or 50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion. The conversion feature of the Nov 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $387 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Nov 2018 Note was $75,000. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of March 31, 2019 was $7,415,615.

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITIES	5. DERIVATIVE LIABILITIES We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations. The convertible notes issued and described in Note 4 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the three months ended March 31, 2019, the Company converted $287,973 in principal of convertible promissory notes, plus accrued interest of $51,378, and a loss on settlement of debt in the amount of $40,500. As a result of the conversion of these notes and the change in fair value of the remaining notes, the Company recorded a loss on conversion of debt in the amount of $514,404 in the statement of operations for the three months ended March 31, 2019. At March 31, 2019, the fair value of the derivative liability was $7,415,615. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation model for the derivative are as follows: 3/31/19 Risk free interest rate 2.21% - 2.60% Stock volatility factor 40.0% - 270.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Restricted Stock and Warrants

Restricted Stock and Warrants	3 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
RESTRICTED STOCKS AND WARRANTS	6. RESTRICTED STOCK AND WARRANTS Restricted Stock to CEO On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued. The August RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “May RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGA are performance based shares and none have yet vested nor have any been issued. The May RSGA provides for the issuance of up to 30,000,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “September RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the September RSGA are performance based shares and none have yet vested nor have any been issued. The September RSGA provides for the issuance of up to 30,000,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Restricted Stock to Employees and Consultants On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “First Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Second Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Second Employee RSGA provides for the issuance of up to 571,429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 285,714 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On November 10, 2017, the Company entered into a Restricted Stock Grant Agreement (the “Third Employee RSGA”) with nine of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Second Consultants RSGA provides to the respective consultants the issuance of an aggregate of 2,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants an aggregate of 1,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employee and Consultant RSGA”) with one of its’ employee and one consultant, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employee and Consultant RSGA are performance based shares and none have yet vested nor have any been issued. The Employee and Consultant RSGA provides to the employee and consultant the issuance of an aggregate of 4,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 2,000,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 9, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employees and Consultants RSGA”) with two of its consultants and two employees, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employees and Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Employees and Consultants RSGA provides to the employees and consultants the issuance of an aggregate of 8,500,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 4,250,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Sep 2018 Consultants RSGA”) with two of its consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Sep 2018 Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Sep 2018 Consultants RSGA provides to the consultants the issuance of an aggregate of 27,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 13,500,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Warrants As of March 31, 2019, the Company issued no warrants during the period. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2019: March 31, 2019 Weighted Number average of exercise Warrants price Outstanding - beginning of the period 250,912,025 $ 5.40 Granted - - Exercised - - Forfeited Outstanding - end of the period 250,912,025 $ 5.40 At March 31, 2019, the weighted average remaining contractual life of warrants outstanding: Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.012 6,824,924 6,824,924 0.17 $ 0.250 244,087,101 244,087,101 2.37 250,912,025 250,912,025 At March 31, 2019, the aggregate intrinsic value of the warrants outstanding was $0.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2019
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	7. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the three months ended March 31, 2019 and 2018. Three Months Ended March 31, 2019 2018 Equipment Contracts $ 446,233 $ 984,754 Component Sales 263,259 307,445 Services Sales 32,551 11,340 Licensing Fees - 30,000 $ 742,043 $ 1,333,539 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the three months ending March 31, 2019 was $104,383 and for the year ending December 31, 2018 was $111,001. The contract liability for the three months ending March 31, 2019 was $132,391 and for the year ending December 31, 2018 was $112,894.

Financial Assets

Financial Assets	3 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	8. FINANCIAL ASSETS Convertible Note Receivable On May 22, 2018, the Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc (“WTII”). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. The Note bears a default clause, which increases the rate of interest to 20% automatic late fee on the unpaid balance, plus the monthly interest increases to 20%, if the accrued interest is not paid per the agreement every six months. As of March 31, 2019, the issuer defaulted on the convertible note, and was charged $16,980 in interest for the period. As of March 31, 2019, the note included principal of $80,000 plus accrued interest of $23,935. Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of March 31, 2019, the fair value of the preferred shares was $15,600.

Loans Payable

Loans Payable	3 Months Ended
	Mar. 31, 2019
Loans Payable [Abstract]
LOANS PAYABLE	9. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans ranged from two months to six months. The balance as of March 31, 2019 was $555,215, less finance cost of $12,566 for a net balance of $542,649.

Related Party Loans Payable

Related Party Loans Payable	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Loans Payable	10. RELATED PARTY LOANS PAYABLE Promissory Note Payable The Company entered into a promissory note payable on July 18, 2018 for the sum of $75,000. The principal consists of $67,500 plus a $7,500 origination fee. The interest is sixty-nine percent per annum. The monthly payments are $4,318, and the maturity date of the Note is August 1, 2028. The note is personally guaranteed by the Company’s CEO. As of March 31, 2019, the maturities are summarized as follows: Promissory note payable $ 74,956 Less current portion 110 Long term portion $ 74,846 Long term maturities for the next five years are as follows: 2020 $ 110 2021 214 2022 419 2023 820 2024 through 2028 73,393 $ 74,956 LOANS PAYABLE – RELATED PARTY The Company’s CEO loaned the Company $248,870 during the year ended December 31, 2018. The loans bear interest at various rates to be at various maturity dates. The funds were used for operating expenses. The principal balance as December 31, 2018 was $219,841. During the three months ended March 31, 2019, the Company made principal payments in the amount of $15,674, leaving a balance of $204,167 as of March 31, 2019.

Capital Leases

Capital Leases	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
CAPITAL LEASES	11. CAPITAL LEASES The Company entered into a five (5) year equipment lease in the amount of $45,440, which was recorded as a capital lease. The lease is for a sixty (60) month term, and there are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month. The future minimum lease payments due as March 31, 2019 is $33,734. As of March 31, 2019, the maturities are summarized as follows: Capital lease $ 33,734 Less current portion 9,088 Total long-term liabilities $ 24,646 Long term maturities for the next four years are as follows: Period Ending March 31, 2019 $ 9,088 2020 9,088 2021 9,088 2022 6,470 $ 33,734

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	11. COMMITMENTS AND CONTINGENCIES Operating Lease – Related Party The Company entered into a month-to-month lease agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,750 per month. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	12. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: On April 3, 2019, the “Company filed a certificate of designation (the “Series I COD”) of Series I Preferred Stock (the “Series I”) and a certificate of designation (the “Series J COD”) of Series J Preferred Stock (the “Series J”). Pursuant to the Series I COD, the Company designated 4,000 shares of preferred stock as Series I. The Series I will have a stated value of $1,000 per share, and will be entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. Pursuant to the Series J COD, the Company designated 100,000 shares of preferred stock as Series J. The Series J will have a stated value of $1,000 per share, and will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J will be convertible into validly-issued, fully paid and non-assessable shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed Series F Preferred Stock and Series G Preferred Stock. Between April 4, 2019 and May 13, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 615 shares of the Company’s Series I preferred stock for an aggregate purchase price of $615,000. The Company also issued an aggregate of 307.5 shares of its Series J preferred stock to the investors. On April 19, 2019, the Company entered into Restricted Stock Grant Agreements (the “April RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, three members of the Board and five consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the April RSGAs are performance based shares and none have yet vested nor have any been issued. The April RSGAs provide for the issuance of up to an aggregate of 90,000,000 shares of the Company’s common stock as follows: 30,000,000 to the CEO, 5,000,000 to each of the other three members of the Board and an aggregate of 45,000,000 to five consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 45,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On April 23, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 to 16,000,000,000. Between April 23, 2019 and May 6, 2019, holders of convertible notes, known in our filings as “Convertible Promissory Notes” converted an aggregate outstanding principal and interest amount of $86,390 into an aggregate of 228,235,283 shares of the Company’s common stock. In connection with certain one-time make good agreements, on April 30, 2019, the Company issued an aggregate of 9,178,744 shares of its common stock to certain holders of its common stock. Between April 17, 2019 and April 30, 2019, the Company issued to consultants an aggregate of 43,888,889 shares of the Company’s common stock in lieu of cash considerations.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities.
Loss per Share Calculations	Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Three Months Ended March 31, 2019 The Company has excluded 250,912,025 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,799,009, and shares issuable from convertible preferred stock for the three months ended March 31, 2019, because their impact on the loss per share is anti-dilutive. Three Months Ended March 31, 2018 The Company has excluded 3,714,637 shares of common stock issuable pursuant to outstanding stock options, 40,931,531 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,543,068 and shares of common stock issuable pursuant to outstanding convertible preferred stock for the three months ended March 31, 2018, because their impact on the loss per share is anti-dilutive.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $6,996 as of March 31, 2019 and December 31, 2018, respectively. The net contract receivable balance was $289,689 and $309,223 at March 31, 2019 and December 31, 2018, respectively.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2019, the balances reported for cash, contract receivables, contract assets, prepaid expenses, accounts payable, contract liabilities, and accrued expenses, and derivative instruments approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 15,600 $ 15,600 $ - $ - Total Assets measured at fair value $ 15,600 $ 15,600 $ - $ - The following is a reconciliation of the fair value securities for which level 3 inputs were used in determining the approximate fair value: Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,415,615 $ - $ - $ 7,415,615 Total liabilities measured at fair value $ 7,415,615 $ - $ - $ 7,415,615 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Gain on net change in derivative liability (1,944,589 ) Balance as of March 31, 2019 $ 7,415,615 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/19 Risk free interest rate 2.21% - 2.60% Stock volatility factor 40.0% - 270.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material effect on the Company’s consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s financial statements, which had no material effect. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The impact of the adoption of ASU 2018-07 on the Company’s financial statements did not have a material impact. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.
Reclassification of Expenses	Reclassification of Expenses During the period, the Company reclassified certain expenses in the prior period ended March 31, 2018 to conform to the current period. There was no material effect to the financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Tables)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 15,600 $ 15,600 $ - $ - Total Assets measured at fair value $ 15,600 $ 15,600 $ - $ -
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,415,615 $ - $ - $ 7,415,615 Total liabilities measured at fair value $ 7,415,615 $ - $ - $ 7,415,615
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Gain on net change in derivative liability (1,944,589 ) Balance as of March 31, 2019 $ 7,415,615
Schedule of fair market value of derivative liability assumptions	3/31/19 Risk free interest rate 2.21% - 2.60% Stock volatility factor 40.0% - 270.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes, net of debt discount $ 3,785,481 Less current portion 2,717,353 Total long-term liabilities $ 1,068,128
Schedule of maturities of long-term debt	Period Ending March 31, 2019 Amount 2020 2,717,353 2021 970,000 2022 25,000 2023 73,128 $ 3,785,481

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair market value of the derivative liability	3/31/19 Risk free interest rate 2.21% - 2.60% Stock volatility factor 40.0% - 270.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Restricted Stock and Warrants (

Restricted Stock and Warrants (Tables)	3 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of warrant activity	March 31, 2019 Weighted Number average of exercise Warrants price Outstanding - beginning of the period 250,912,025 $ 5.40 Granted - - Exercised - - Forfeited Outstanding - end of the period 250,912,025 $ 5.40
Schedule of weighted average remaining contractual life of warrants outstanding	Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.012 6,824,924 6,824,924 0.17 $ 0.250 244,087,101 244,087,101 2.37 250,912,025 250,912,025

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2019
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Three Months Ended March 31, 2019 2018 Equipment Contracts $ 446,233 $ 984,754 Component Sales 263,259 307,445 Services Sales 32,551 11,340 Licensing Fees - 30,000 $ 742,043 $ 1,333,539

Related Party Loans Payable (Ta

Related Party Loans Payable (Tables)	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Schedule of loans payable	Promissory note payable $ 74,956 Less current portion 110 Long term portion $ 74,846
Schedule of long term maturities	Long term maturities for the next five years are as follows: 2020 $ 110 2021 214 2022 419 2023 820 2024 through 2028 73,283 $ 74,846

Capital Leases (Tables)

Capital Leases (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Schedule of maturities	Capital lease $ 33,734 Less current portion 9,088 Total long-term liabilities $ 24,646
Schedule of long term maturities	Period Ending March 31, 2019 $ 9,088 2020 9,088 2021 9,088 2022 6,470 $ 33,734

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details)	Mar. 31, 2019USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	$ 15,600
Total Assets measured at fair value	15,600
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	15,600
Total Assets measured at fair value	15,600
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details 2) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Schedule of fair value of financial instruments
Derivative Liability	$ 7,415,615	$ 9,360,204
Total liabilities measured at fair value	13,489,132	$ 14,062,878
Level 1 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
Level 2 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
Level 3 [Member]
Schedule of fair value of financial instruments
Derivative Liability	7,415,615
Total liabilities measured at fair value	$ 7,415,615

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details 3) - Fair Value, Inputs, Level 3 [Member]	3 Months Ended
	Mar. 31, 2019USD ($)
Schedule of reconciliation of the derivative liability for which Level 3 inputs
Beginning balance	$ 9,360,204
Fair Value of derivative liabilities issued
Gain on net change in derivative liability	(1,944,589)
Ending balance	$ 7,415,615

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details 4) - Derivative liability [Member]	3 Months Ended
	Mar. 31, 2019
Schedule of fair market value of derivative liability assumptions
Expected dividend yield
Minimum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	2.21%
Stock volatility factor	40.00%
Weighted average expected option life	3 months
Maximum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	2.60%
Stock volatility factor	270.00%
Weighted average expected option life	5 years

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details Textual)	3 Months Ended
	Mar. 31, 2019USD ($)Segmentsshares	Mar. 31, 2018USD ($)shares	Dec. 31, 2018USD ($)
Summary of Significant Accounting Polices (Textual)
Allowance for doubtful accounts	$ 6,996		$ 6,996
Contract receivable	$ 289,689		$ 309,223
Number of segment reporting | Segments	1
Outstanding convertible debt		$ 252,750
Warrant [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares	250,912,025	40,931,531
Employee Stock Option [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares		3,714,637
Common Stock [Member]
Summary of Significant Accounting Polices (Textual)
Outstanding convertible debt	$ 3,799,009	$ 3,543,068

Capital Stock (Details)

Capital Stock (Details) - USD ($)	Aug. 14, 2018	Aug. 09, 2018	Apr. 13, 2018	Apr. 11, 2018	Mar. 14, 2017	Jan. 16, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Capital Stock (Textual)
Series D Preferred stock issued through a private placement
Preferred stock, shares authorized							550,000,000		550,000,000
Fair value loss on settlement							$ 40,500
Common stock, shares authorized							8,000,000,000		8,000,000,000
Accrued dividends							$ 4,596
Common Stock [Member]
Capital Stock (Textual)
Issuance of common stock, shares
Series D Preferred stock issued through a private placement
Common stock for settlement of convertible promissory notes							626,028,289	7,442,162
Aggregate principal amount							$ 284,973	$ 50,000
Interest amount							$ 51,578	$ 16,679
Common stock issued for services, shares							233,078,882	15,256,054
Common stock issued for services							$ 279,229	$ 402,512
Debt conversion amount							514,404	$ 126,330
Fair value loss on settlement							$ 40,500
Common Stock [Member] | Maximum [Member]
Capital Stock (Textual)
Conversion price							$ 0.0018	$ 0.0329
Common Stock [Member] | Minimum [Member]
Capital Stock (Textual)
Conversion price							$ 0.0009	$ 0.019
Series E Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding							2,139,649		2,139,649
Description of convertible preferred stock terms	The Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the "Series E preferred stock") with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock into a number of shares of common stock equal to the greater of (A) 100 shares of common stock and (B) the number of shares of common stock the holder would have received pursuant to such holder's respective subscription agreement if the preferred shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is 50% of the purchase price paid by any purchase of the Series E preferred stock. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days' notice. In connection with the issuance of the Series E preferred stock, the Company also issued one hundred warrants to purchase shares of common stock for each share of Series E preferred stock. As of March 31 2019, there were 2,139,649 shares of Series E preferred stock issued and outstanding.
Series F Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares issued							1,678
Preferred stock, shares outstanding							1,678
Description of convertible preferred stock terms	The Company filed a Certificate of Designation for its Series F Convertible preferred stock (the "Series F preferred stock") with the Secretary of State of Nevada designating 6,000 shares of Series F Preferred Stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F Preferred Stock have a liquidation preference of stated value per share of $1,000 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock or any other series of capital stock (other than the Series B Preferred Stock) then-existing or thereinafter created. The Series F preferred stock is not convertible into common stock. The shares of Series F preferred stock do not carry any voting rights. The holders of Series F Preferred Stock will be entitled to receive, of any funds and assets of the Company legally available prior and in preference to any declaration or payment of any dividend on the common stock, cumulative dividends, payable quarterly (at the end of each fiscal quarter, and due for such fiscal quarter within fifteen days of the end of such fiscal quarter), at an annual rate of 8% of the stated value. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. As of March 31, 2019, the Company accrued dividends in the amount of $33,560. As of March 31, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding.
Convertible preferred stock, share issued							1,743
Series D Preferred Stock One [Member]
Capital Stock (Textual)
Preferred stock, shares issued							38,500,000
Preferred stock, par value				$ 0.0001
Preferred stock, shares outstanding							38,500,000		38,500,000
Preferred stock, shares authorized				50,000,000
Description of convertible preferred stock terms			The Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the "Series D-1 preferred stock") with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into the greater of (A) one share of common stock and (B) the number of shares of common stock the holder would have received pursuant to each holder's respective subscription agreement if the Series D-1 Preferred Shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is $0.005 (1/2 of one cent). The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days' notice. The Company issued an aggregate of 38,500,000 Series D-1 preferred shares for services. As of March 31, 2019, there were 38,500,000 Series D-1 preferred shares issued and outstanding.
Series D Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, par value				$ 0.0001
Preferred stock, shares authorized				400,000,000
Description of convertible preferred stock terms			The Board adopted resolutions creating a series of shares of convertible preferred stock designated as 0% Series D preferred stock (the "Series D preferred stock") with a par value of $0.0001. The shares of Series D preferred stock do not have a dividend rate or liquidation preference and do not carry any voting rights. The purchase price shall be $0.02 per unit for an aggregate investment amount of less than $50,000; $0.018 for an aggregate amount of $50,000 or greater, but less than $100,000; $0.016 for an aggregate amount of $100,000 or greater, but less than $250,000; $0.014 for an aggregate amount of $250,000 or greater. At no time may all or a portion of the Series D preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion.
Series G Preferred Stock [Member]
Capital Stock (Textual)
Issuance of common stock, shares							165,598,887
Description of convertible preferred stock terms						The Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the "Series G Designation"). Pursuant to the Series G Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000, and pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company's common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company's Series G preferred stock for an aggregate purchase price of $530,000. As of March 31, 2019, the Company issued an aggregate of 165,598,887 shares of its common stock to certain holders of its Series G preferred stock.
Common Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms		The Company and Board of Directors increased the aggregate number of authorized shares of common stock of the Corporation to 8,000,000,000 shares from 2,000,000,000 shares.
Series C Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, par value					$ 0.0001
Preferred stock, shares outstanding							1,000		1,000
Purchase price of the Series C preferred stock					$ 0.10
Total purchase price Series C preferred stock, shares					1,000
Series C Preferred Stock [Member] | President [Member]
Capital Stock (Textual)
Preferred stock, shares issued					1,000
Preferred stock, par value					$ 0.0001
Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms				The Board of Directors authorized an increase in shares of preferred stock, par value $0.0001 per share to 550,000,000 shares from 750,000 shares.

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Convertible Promissory Notes, net of debt discount	$ 3,785,481
Less current portion	2,717,353	$ 1,580,955
Total long-term liabilities	$ 1,068,128

Convertible Promissory Notes _2

Convertible Promissory Notes (Details 1) - Convertible Promissory Notes [Member]	Mar. 31, 2019USD ($)
Maturities of long-term debt
2020	$ 2,717,353
2021	970,000
2022	25,000
2023	73,128
Total	$ 3,785,481

Convertible Promissory Notes _3

Convertible Promissory Notes (Details Textual) - USD ($)	Mar. 13, 2019	Nov. 30, 2018	Feb. 23, 2018	Mar. 31, 2019	Aug. 28, 2018	Dec. 31, 2018
Convertible Promissory Notes (Textual)
Convertible promissory notes				$ 1,068,128		$ 2,076,472
Debt instrument, maturity date		Nov. 30, 2019
Derivative liability				7,415,615		$ 9,360,204
Fair value loss on settlement				40,500
Loss on conversion of debt				$ 514,404
Issued an unsecured convertible promissory notes		$ 75,000
Sep 2016 Note [Member]
Convertible Promissory Notes (Textual)
Description of debt instrument				In exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company's common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the time it was entered into, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of March 31, 2019, the remaining balance on the Sep 2016 Note was $430,896.
Unsecured Convertible Notes Four [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate				10.00%
Converted an aggregate principal amount				$ 81,000	$ 293,000
Number of shares converted into common stock				148,027,924
Recognized interest expense				$ 42,260
Accrued interest				$ 5,903
Conversion price per share of debt, description				The Company's common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion.
Fair value loss on settlement				$ 40,500
Loss on conversion of debt				$ 99,667
2015-2016 Notes [Member]
Convertible Promissory Notes (Textual)
Description of debt instrument				On various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per annum. The 2015-2016 Notes may be converted into shares of the Company's common stock at conversion prices ranging from the lesser of $0.70 to $2.80 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of March 31, 2019, was $1,325,000.
Notes [Member]
Convertible Promissory Notes (Textual)
Conversion price per share of debt, description				The Notes bear interest at 10% per annum. The Notes may be converted into shares of the Company's common stock at conversion prices ranging from the lesser of $2.10 to $4.90 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes.
Unsecured Convertible Notes Six [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate				10.00%
Converted an aggregate principal amount				$ 6,523
Number of shares converted into common stock				25,000,000
Aggregate remaining amount				$ 300,000
Recognized interest expense				39,128
Accrued interest				4,727
Conversion price per share of debt, description	The Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 5,261,538,462 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but no limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company's common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company's common stock (the "Make-Whole Shares"). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $39,128 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Apr & May 2018 Notes were $515,162.
Fair value loss on settlement				$ 16,250
Unsecured Convertible Notes Two [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate				10.00%
Debt instrument, maturity date				May 19, 2020
Aggregate remaining amount				$ 1,325,000
Conversion price per share of debt, description		The Nov 2018 Note bears interest at 10% per annum. The Nov 2018 Note may be converted into shares of the Company's common stock at a fixed conversion price of $0.05 per share or 50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion. The conversion feature of the Nov 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $387 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Nov 2018 Note was $75,000.		After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Convertible promissory notes				$ 3,799,009
Remaining debt discount				13,528
Net balance				$ 3,785,481
Debt instrument interest rate				10.00%
Converted an aggregate principal amount				$ 86,800
Number of shares converted into common stock				240,596,661
Derivative liability				$ 430,896
Aggregate remaining amount				1,192,500
Accrued interest				$ 37,989
Conversion price per share of debt, description				50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
Fair value loss on settlement				$ 190,873
Original Issue Discount Notes [Member]
Convertible Promissory Notes (Textual)
Remaining debt discount				$ 73,128
Debt instrument, maturity date				Jun. 30, 2018
Accrued interest				$ 143,228
Conversion price of debt				$ 15.31
Conversion price per share of debt, description				The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes matured on June 30, 2018, and were extended through June 30, 2023. The OID Notes were convertible into shares of the Company's common stock at a conversion price initially of $15.31. After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Convertible Debt [Member]
Convertible Promissory Notes (Textual)
Aggregate remaining amount				$ 167,048
Description of debt instrument				Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note				$ 432,048
Percentage of average of lowest closing prices				75.00%
Number of trading days previous to conversion				25 days
Convertible Debt One [Member]
Convertible Promissory Notes (Textual)
Recognized interest expense				$ 430,896
Description of debt instrument				Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note				$ 430,896
Unsecured Convertible Notes Five [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate				10.00%
Additional notes issuance			$ 78,750
Converted an aggregate principal amount			157,500	$ 40,550
Number of shares converted into common stock				72,182,282
Recognized interest expense				$ 50,702
Accrued interest				$ 2,759
Conversion price per share of debt, description				The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company's common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the period ended March 31, 2019, the Company entered into a settlement agreement with the investor in the amount of $20,275 (50% of the outstanding balance of $40,550 as of date of settlement), based on the outstanding balance due and payable under the Notes. During the three months ended March 31, 2019, the Company issued 72,182,282 shares of common stock, upon conversion of principal in the amount of $40,550, plus accrued interest of $2,759, with a fair value loss on settlement of $81,469. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $50,702 during the three months ended March 31, 2019. As of March 31, 2019, the remaining balance on the Feb 2018 Notes were $20,275.
Fair value loss on settlement				$ 81,469
Aggregate principal each amount			$ 78,750
Notes maturity date				Feb. 23, 2019

Derivative Liabilities (Details

Derivative Liabilities (Details) - Fair market value of the derivative liability [Member]	3 Months Ended
	Mar. 31, 2019
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Expected dividend yield
Minimum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	2.21%
Stock volatility factor	40.00%
Weighted average expected option life	3 months
Maximum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	2.60%
Stock volatility factor	270.00%
Weighted average expected option life	5 years

Derivative Liabilities (Detai_2

Derivative Liabilities (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Derivative Liabilities (Textual)
Principal amount of convertible promissory notes	$ 287,973
Accrued interest	51,378
Loss on conversion of debt amount	514,404
Fair value of the derivative liability	7,415,615	$ 9,360,204
Fair value loss on settlement	$ 40,500

Restricted Stock and Warrants_2

Restricted Stock and Warrants (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Number of Warrants
Outstanding - beginning of the period | shares	250,912,025
Granted | shares
Exercised | shares
Forfeited | shares
Outstanding - end of the period | shares	250,912,025
Weighted average exercise price
Outstanding - beginning of the period | $ / shares	$ 5.40
Granted | $ / shares
Exercised | $ / shares
Forfeited | $ / shares
Outstanding - end of the period | $ / shares	$ 5.40

Restricted Stock and Warrants_3

Restricted Stock and Warrants (Details 1) - Warrant [Member]	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Warrants Outstanding	250,912,025
Warrants Exercisable	250,912,025
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 0.012
Warrants Outstanding	6,824,924
Warrants Exercisable	6,824,924
Weighted Average Remaining Contractual Life (years)	2 months 1 day
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 0.250
Warrants Outstanding	244,087,101
Warrants Exercisable	244,087,101
Weighted Average Remaining Contractual Life (years)	2 years 4 months 13 days

Restricted Stock and Warrants_4

Restricted Stock and Warrants (Details Textual) - USD ($)	Aug. 09, 2018	Nov. 10, 2017	Aug. 10, 2016	May 12, 2016	Sep. 28, 2018	May 16, 2018	Mar. 31, 2019
Restricted Stock and Warrants (Textual)
Warrants outstanding							$ 0
Employee and Consultant RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares	8,500,000				27,000,000	4,000,000
Restricted stock grant agreement, description	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 4,250,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 4,250,000 shares of its common stock to respective consultants, in various amounts of its common stock.				The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 13,500,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 13,500,000 shares of its common stock to respective consultants, in various amounts of its common stock.	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 2,000,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 2,000,000 shares of its common stock to the respective employee and consultant, in various amounts of its common stock.
Third Employee RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares		2,000,000
Restricted stock grant agreement, description		The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants an aggregate of 1,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 1,000,000 shares to the respective consultants, its common stock.
Consultants [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares			285,714
Restricted stock grant agreement, description			The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 142,857 shares to each of the consultants, its common stock.
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares			1,714,286	1,714,286	30,000,000
Restricted stock grant agreement, description			The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.	The Company's common stock to the Employees provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.	The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 15,000,000 shares of its common stock.
Employees [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares				857,143
Restricted stock grant agreement, description				The Company's common stock to the employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 428,571 shares of its common stock.
Employees One [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares				571,429
Restricted stock grant agreement, description				The Company's common stock to the employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 285,714 shares of its common stock.
May RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares						30,000,000
Restricted stock grant agreement, description						The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 15,000,000 shares of its common stock.

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue from Contracts with Customers [Abstract]
Equipment Contracts	$ 446,233	$ 984,754
Component Sales	263,259	307,445
Services Sales	32,551	11,340
Licensing Fees		30,000
Total	$ 742,043	$ 1,333,539

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details Textual) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Revenue from Contracts with Customers (Textual)
Contract assets	$ 104,383	$ 111,001
Contract liability	$ 132,391	$ 112,894

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	May 22, 2018	Mar. 31, 2019	Dec. 31, 2018
Financial Assets (Textual)
Convertible note accrued interest			$ 51,378
Financial asset, description	The Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock.
Preferred shares fair value			$ 15,600	$ 22,800
Convertible Note Receivable [Member]
Financial Assets (Textual)
Purchased of convertible note, percentage		10.00%
Convertible note		$ 80,000
Convertible note price			65.00%
Conversion price per share			$ 0.0001
Convertible note principal amount			$ 80,000
Convertible note accrued interest			$ 23,935
Convertible note receivable description			The Note bears a default clause, which increases the rate of interest to 20% automatic late fee on the unpaid balance, plus the monthly interest increases to 20%, if the accrued interest is not paid per the agreement every six months. As of March 31, 2019, the issuer defaulted on the convertible note, and was charged $16,980 in interest for the period.

Loans Payable (Details)

Loans Payable (Details)	3 Months Ended
	Mar. 31, 2019
Secured Loans Payable [Member]
Loans Payable (Textual)
Description of debt instrument	Short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans ranged from two months to six months. The balance as of March 31, 2019 was $555,215, less finance cost of $12,566 for a net balance of $542,649.

Related Party Loans Payable (De

Related Party Loans Payable (Details)	Mar. 31, 2019USD ($)
Summary of maturities
Promissory note payable	$ 74,956
Less current portion	110
Long term portion	$ 74,846

Related Party Loans Payable (_2

Related Party Loans Payable (Details 1) - Promissory Note Payable [Member]	Mar. 31, 2019USD ($)
Long term maturities for the next five years are as follows:
2020	$ 110
2021	214
2022	419
2023	820
2024 through 2028	73,393
Long term portion	$ 74,956

Related Party Loans Payable (_3

Related Party Loans Payable (Details Textual) - Debt [Member]	3 Months Ended
	Mar. 31, 2019
Related Party Loans Payable (Textual)
Description of debt instrument	A promissory note payable on July 18, 2018 for the sum of $75,000. The principal consists of $67,500 plus a $7,500 origination fee. The interest is sixty-nine percent per annum. The monthly payments are $4,318, and the maturity date of the Note is August 1, 2028. The note is personally guaranteed by the Company?s CEO.
Related party loans payable, Description	The Company $248,870 during the year ended December 31, 2018. The loans bear interest at various rates to be at various maturity dates. The funds were used for operating expenses. The principal balance as December 31, 2018 was $219,841. During the three months ended March 31, 2019, the Company made principal payments in the amount of $15,674, leaving a balance of $204,167 as of March 31, 2019.

Capital Leases (Details)

Capital Leases (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Capital lease	$ 33,734
Less current portion	9,088
Total long-term liabilities	$ 24,646	$ 26,918

Capital Leases (Details 1)

Capital Leases (Details 1)	Mar. 31, 2019USD ($)
Leases [Abstract]
2019	$ 9,088
2020	9,088
2021	9,088
2022	6,470
Total	$ 33,734

Capital Leases (Details Textual

Capital Leases (Details Textual)	3 Months Ended
	Mar. 31, 2019USD ($)$ / shares
Capital Lease (Textual)
Capital lease term	60 months
Lease price | $ / shares	$ 1
Equipment lease term	5 years
Capital lease amount	$ 45,440
Description of operating lease	There are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month.
Future minimum lease payments due	$ 33,734

Commitments and Contingencies (

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2019USD ($)
Commitments and Contingencies (Textual)
Warrant reserve	$ 20,000
McKinney [Member]
Commitments and Contingencies (Textual)
Base rent	$ 4,750

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	May 06, 2019	Apr. 30, 2019	Apr. 03, 2019	May 13, 2019	Apr. 30, 2019	Apr. 23, 2019	Apr. 19, 2019
Subsequent Events (Textual)
Subsequent event, description			The Company designated 4,000 shares of preferred stock as Series I. The Series I will have a stated value of $1,000 per share, and will be entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of.
Shares issued			100,000
Description of common stock shares authorized						The Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 to 16,000,000,000.
Shares issued per share			$ 1,000
Convertible Promissory Notes [Member]
Subsequent Events (Textual)
Aggregate principal and interest amount	$ 86,390
Aggregate shares of common stock	228,235,283
Series I Preferred Stock [Member]
Subsequent Events (Textual)
Aggregate shares sold				615
Aggregate purchase price				$ 615,000
Series J Preferred Stock [Member]
Subsequent Events (Textual)
Subsequent event, description				In connection with the Series I Designation and Series J Designation, the Company issued an aggregate of 307.5 shares of its Series J preferred stock to certain holders of its Series I and Series J Preferred Stock.
Common Stock [Member]
Subsequent Events (Textual)
Aggregate shares of common stock		43,888,889			9,178,744
Restricted Stock Grant Agreement [Member]
Subsequent Events (Textual)
Subsequent event, description							The Company entered into Restricted Stock Grant Agreements (the "April RSGAs") with its Chief Executive Officer, Riggs Eckelberry, three members of the Board and five consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the April RSGAs are performance based shares and none have yet vested nor have any been issued. The April RSGAs provide for the issuance of up to an aggregate of 90,000,000 shares of the Company's common stock as follows: 30,000,000 to the CEO, 5,000,000 to each of the other three members of the Board and an aggregate of 45,000,000 to five consultants provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 45,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to an aggregate of 45,000,000 shares of its common stock.